Market Overview:
The Surgical Mesh Market size is expected to grow from USD 2158.13 Million in 2022 to USD 3854.71 Million by 2030, at a CAGR of 7.52% during the forecast period.
Surgical mesh is a medical device utilized to provide support to weakened or damaged tissue during the healing process. It finds extensive application in Urogynecologic procedures, particularly in the treatment of pelvic organ prolapse (POP) and stress urinary incontinence (SUI). These conditions benefit from surgical mesh, which can be either synthetic (man-made) or derived from animal tissue. In treating SUI, the mesh is implanted to offer permanent support to the urethra or bladder neck, while in POP treatment, it strengthens the weakened vaginal wall. Synthetic surgical mesh can be found in two common forms: knitted mesh and non-knitted sheets.
Top Key Players in Surgical Mesh Market:
W. L. Gore & Associates. Inc. (U.S), Boston Scientific Corporation (U.S), M?lnlycke Health Care AB (Sweden), Medical Devices Business Services, Inc. (U.S), BD (U.S), TEPHA INC. (U.S), Medtronic (Ireland), LifeCell International Pvt. Ltd. (India), B. Braun Melsungen AG (Germany), Betatech Medical (Turkey), Ethicon Inc (U.S), C.R. Bard, Inc (U.S), Atrium (U.S) and other major players.
Market Dynamics and Factors for Surgical Mesh Market:
Drivers:
Growing Numbers of Hernia Patients
The increasing number of hernia patients has been a significant driver for the growth of the surgical mesh market. Hernia is a common medical condition where an organ or fatty tissue protrudes through a weak spot or tear in the surrounding muscle or connective tissue. Surgical mesh is widely used in hernia repair procedures to provide support and reinforcement to the weakened area, reducing the risk of recurrence and promoting faster healing. With an aging population, the incidence of hernias tends to increase. As people age, their muscles and tissues may weaken, making them more susceptible to hernias. The global rise in obesity rates has also contributed to the growing number of hernia cases. Obesity puts extra pressure on the abdominal muscles, increasing the likelihood of developing hernias.
Opportunities:
Adopting and Developing Cutting-Edge Technologies
Adopting and developing cutting-edge technologies present significant opportunities for the surgical mesh market. Ongoing research and development efforts in biomaterials have led to the creation of advanced mesh materials with improved biocompatibility and strength. These innovative materials offer better integration with the patient's tissues, reduced risk of complications, and enhanced long-term durability.
The development of biodegradable surgical meshes is an exciting area of research. These meshes gradually dissolve over time, leaving behind native tissue without a permanent implant. Biodegradable meshes may help reduce the risk of long-term complications and the need for potential mesh removal surgeries.
Segmentation Analysis of the Surgical Mesh Market:
By Product Type, the Synthetic Surgical Meshes segment had the largest market share. Synthetic surgical meshes are medical devices made from man-made materials and are widely used in various surgical procedures to reinforce and support weakened or damaged tissues. They are commonly employed in hernia repair surgeries, pelvic organ prolapse (POP) repairs, and stress urinary incontinence (SUI) procedures, among others.
By Application, Hernia Repair is likely to dominate in this area. The surgical mesh market has experienced significant growth over the years, primarily driven by the increasing number of hernia repair procedures.
Regional Analysis of the Surgical Mesh Market:
North America dominates the surgical mesh market. Due to the prevalence of hernia disorders and the availability of cutting-edge treatment options, the market for surgical meshes is primarily driven in North America. Also, the Surgical Mesh Industry is forecast to expand most rapidly in Asia-Pacific, primarily as a result of increasing demand and healthcare spending in the region. The market for surgical meshes is highly concentrated in North America due to the high prevalence of hernia disorders and the availability of innovative treatment options.
Key Industry Development:
In February 2022, Dolphin Mesh by Futura Surgicare Pvt Ltd launched a surgical mesh range which are premium dual meshes used in ?tension-free? and laparoscopic tension-free hernia repairs.
In August 2022, Ariste Medical received United States Food and Drug Administration 510(k) clearance for its drug-embedded, synthetic hernia mesh to reduce the risk of microbial colonization during implantation.
